The DOI matches its Crossref record.
miR-200b and miR-200c as Prognostic Factors and Mediators of Gastric Cancer Cell Progression
Abstract
Purpose: The purpose of this study was to investigate the clinicopathologic significance and potential role of miR-200b and miR-200c in the development and progression of gastric cancer. Experimental Design: We examined miR-200b and miR-200c expression in 36 paired normal and stomach tumor specimens, as well as gastric cancer cell lines, by quantitative real-time PCR. In addition, miR-200b and miR-200c were detected by ISH using gastric cancer tissue microarrays, and the association between miR-200b and miR-200c levels and clinicopathologic factors and prognosis were analyzed. A luciferase assay was conducted for target evaluation. The functional effects of miR-200b and miR-200c on gastric cancer cells were validated by a cell proliferation assay and cell invasion and migration assays. Results: miR-200b and miR-200c were downregulated in the gastric cancer specimens and cell lines tested. miR-200b and miR-200c levels were significantly correlated with the clinical stage, T stage, lymph node metastasis, and survival of patients. Ectopic expression of miR-200b and miR-200c impaired cell growth and invasion. In addition, when overexpressed, miR-200b and miR-200c commonly directly targeted DNMT3A, DNMT3B, and SP1 (a transactivator of the DNMT1 gene), which resulted in marked reduction of the expression of DNA methyltransferases DNMT1, DNMT3A, and DNMT3B at the protein level. This effect, in turn, led to a decrease in global DNA methylation and reexpression of p16, RASS1A1, and E-cadherin via promoter DNA hypomethylation. Conclusion: Our findings suggest that miR-200b and miR-200c, as valuable markers of gastric cancer prognosis, may be a promising approach to human gastric cancer treatment. Clin Cancer Res; 19(20); 5602–12. ©2013 AACR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Humphries, B., & Yang, C. (2015) · Oncotarget · doi:10.18632/oncotarget.3052 · Cited by 346
circEPSTI1 as a Prognostic Marker and Mediator of Triple-Negative Breast Cancer Progression
Chen, B., Wei, W., Huang, X., Xie, X., Kong, Y., Dai, D., Yang, L., Wang, J., Tang, H., & Xie, X. (2018) · Theranostics · doi:10.7150/thno.24106 · Cited by 281
Self-citationYu, L., Wu, D., Gao, H., Balic, J. J., Tsykin, A., Han, T.-S., Liu, Y. D., Kennedy, C. L., Li, J. K., Mao, J. Q., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-2485 · Cited by 50
“In addition, the miR-200 family has been identified as a key regulatory network that defines a mesenchymal gastric cancer subtype associated with poor survival (13, 14).”
BackgroundResultemiRIT: a text-mining-based resource for microRNA information
Roychowdhury, D., Gupta, S., Qin, X., Arighi, C. N., & Vijay-Shanker, K. (2021) · Database · doi:10.1093/database/baab031 · Cited by 15
dos Santos, E. C., Rohan, P., Binato, R., & Abdelhay, E. (2023) · Cancers · doi:10.3390/cancers15225374 · Cited by 3
Metadata
- Authors
- Tang, H., Deng, M., Tang, Y., Xie, X., Guo, J., Kong, Y., Ye, F., Su, Q., & Xie, X.
- Venue
- Clinical Cancer Research
- Published
- 2013-10-14
- Volume
- 19
- Issue
- 20
- Pages
- 5602-5612
- ISSN
- 1078-0432 (ISSN-L)
- 1557-3265
- OpenAlex
- W2151609603
- Cited by
- 160
- References
- 0
- FWCI
- 7.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: miR-200b and miR-200c as Prognostic Factors and Mediators of Gastric Cancer Cell Progression. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-13-1326
- The paper
- Tang, H., Deng, M., Tang, Y., Xie, X., Guo, J., Kong, Y., Ye, F., Su, Q., & Xie, X. (2013). miR-200b and miR-200c as Prognostic Factors and Mediators of Gastric Cancer Cell Progression. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-13-1326
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.